[Hormones and mammographic breast density]

J Radiol. 2008 Sep;89(9 Pt 2):1196-203. doi: 10.1016/s0221-0363(08)73930-1.
[Article in French]

Abstract

Breast constitutional density may be altered and increased (acquired density) by hormonal interventions such as hormone replacement therapy (HRT). The effects of endogenous (steroids, prolactin, insulin-like factors...) and exogenous (HRT, levonorgestrel IUD, tibolone, tamoxifen, SERMs) hormones will be reviewed. Continuous combined estrogen-progestin preparations are most likely to cause an increase in density. Estrogen alone and tibolone are less likely to cause an increase in density. The sensitivity and specificity of mammography are decreased, with increased risk of interval carcinoma and rate of short interval follow-up from false positive results. The issue with regards to interruption of the hormonal therapy prior to mammography, and the duration of the interruption, are discussed.

Publication types

  • Case Reports
  • Comparative Study
  • Review

MeSH terms

  • Adult
  • Aged
  • Biopsy
  • Breast Neoplasms / chemically induced*
  • Breast Neoplasms / diagnostic imaging
  • Breast Neoplasms / pathology
  • Breast* / drug effects
  • Breast* / pathology
  • Contraceptive Agents, Female / pharmacology
  • Diagnosis, Differential
  • Estrogen Replacement Therapy / adverse effects*
  • Female
  • Gonadal Steroid Hormones / physiology
  • Hormones / physiology*
  • Humans
  • Intrauterine Devices
  • Levonorgestrel / pharmacology
  • Mammography*
  • Menopause
  • Menstrual Cycle
  • Middle Aged
  • Norpregnenes / pharmacology
  • Prospective Studies
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Selective Estrogen Receptor Modulators / pharmacology
  • Sensitivity and Specificity
  • Tamoxifen / pharmacology

Substances

  • Contraceptive Agents, Female
  • Gonadal Steroid Hormones
  • Hormones
  • Norpregnenes
  • Selective Estrogen Receptor Modulators
  • Tamoxifen
  • Levonorgestrel
  • tibolone